Results of the Dose-Escalation Portion of a Phase 2 Study of ACE-083, a Local Muscle Therapeutic, in Patients with Charcot-Marie-Tooth (CMT) Disease (S58.006)Florian P. Thomas,Michael Shy,David Herrmann,Jeffrey Statland,David Walk,Colin Quinn,Nicholas Johnson,Sh Subramony,Chafic Karam,Tahseen Mozaffar,Chad E. Glasser,Barry Miller,Ashley Leneus,Robert K. Zeldin,Kenneth M. AttieNeurology(2019)引用 23|浏览34暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要